behavioral pathology

Methods 46 patients with AD were assessed with the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD), mini mental state examination ( MMSE) and the clinic dementia rating ( CDR) at the day of hospitalized.

方法46例AD患者在入院当天作AD病理行为评分表（BEHAVE-AD）、简易智力状态检查（MMSE）及临床痴呆评定表（CDR）评定。

Methods In 30 patients with AD and 30 patients with VD, BPSD were assessed by the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD) and the ( Cohen-) Mansfield Agitation Inventory ( CMAI).

方法对30例AD及30例VD患者，采用Alzheimer病行为症状评定量表（BEHAVE-AD）、Cohen-Mansfield激惹性问卷（CMAI）评定患者BPSD。

BPSD were assessed with the Behavioral Pathology in Alzheimer Disease Rating Scale ( BEHAVE AD) and the Cohen Mansfield Agitation Inventory ( CMAI).

采用Alzheimer病行为症状评定量表（BEHAVE-AD）、Cohen-Masfield激惹性问卷（CMAI）评定痴呆患者BPSD。

To estimate BPSD in AD patients with behavioral pathology in Alzheimer disease rating scale.

采用AD病理行为量表评定病人的行为和精神症状。

The therapeutic response and side effects were evaluated with the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD) and treatment emergent symptom scale ( TESS).

用AD病理行为评分表评价疗效，药物副作用量表评价不良反应。

Objective: To assess the reliability and validity of the behavioral pathology in Alzheimer's disease rating scale ( BEHAVE-AD).

目的：评定阿尔茨海默病（AD）病理行为评分表（BEHAVE-AD）的信度和效度。